|
For Immediate Release: April 29, 2008
Sen. Andrew Rice
Rice Calls Chamber
Memo a ‘Red Herring’, Says Insurance Mandates Save Lives,
Reduce Health Care Costs
A recent State Chamber of Commerce memo to members of the Oklahoma
State Legislature exaggerates the cost of legislative mandates for
insurance coverage, State Senator
Andrew Rice (D-Oklahoma City) said today.
“The truest statement in this memo is that the cost of health
insurance continues to spiral upward,” Rice said. “However,
the Chamber offers no proof that insurance mandates are among the
reasons why.”
Rice is Senate co-author of “Steffanie’s Law”,
legislation to require private insurance companies in Oklahoma to
continue coverage of routine medical care costs even after a cancer
patient enrolls in experimental clinical trials. The bill was inspired
by the late Steffanie Collings, who recently died at the age of
18 after fighting brain cancer for four years.
Collings’ parents are now strapped with over $450,000 in
unpaid medical bills because the family’s insurance company
disqualified Steffanie from coverage after she participated in clinical
trials to find a possible cure.
“Republican leaders in the House of Representatives and their
allies in the insurance industry continue to make insurance mandates
the fall guy for rising health care costs,” Rice said. “However,
research by the American Cancer Society shows that there is very
little difference in the cost of routine medical care for patients
in clinical trials and patients who do not participate.”
Research has shown that lack of insurance coverage is a significant
barrier to many patients who might otherwise enroll in a clinical
trial. Lack of coverage also makes it harder for researchers to
successfully conduct trials that could improve prevention and treatment
options, Rice said.
Rice pointed to other examples where insurance mandates have led
to healthier lifestyles and reduced health care costs in the long
run. A 1996 legislative mandate that required insurance companies
in Oklahoma to cover costs of diabetes testing and treatment is
one example.
“Diabetes is a devastating disease that affects more than
20 million Americans and unless they were forced to do so, some
health insurance companies would not cover the costs of tests that
can detect it early and prevent heart disease, strokes and other
complications,” Rice said. “When the Chamber of Commerce
claims that every mandate increases health insurance premiums, they
are ignoring the long term health savings that occur when patients
are encouraged to seek preventive treatments.”
Rice also cited breast and colorectal screenings as examples of
early detection treatments for women that help prevent high-cost
cancer illness later on.
“The Chamber of Commerce asks Members of the Legislature
to continue allowing the free market to pick winners and losers
among cancer patients,” Rice said. “However, on numerous
occasions a bipartisan majority in both the House and Senate have
made it clear that we want fairness and common sense in the treatment
of our constituents by insurance companies in Oklahoma.”
Rice said that various studies in the 24 states that currently
mandate coverage of routine medical costs for patients in clinical
trials indicate that it adds less than 1 percent to the immediate
cost of insurance. Patients on Medicare who elect to undergo clinical
trials retain coverage of their medical expenses. Cost of the clinical
trials themselves are normally paid by prescription companies and
health care research facilities where they are conducted.
In the current state legislative session, Rice has gained passage
of Steffanie’s Law by a bipartisan majority in the State Senate
but the bill has remained blocked in the Republican-controlled House
of Representatives.
For more information contact:
Senator Rice's Office: (405) 521-5610

|